1. Home
  2. ATR vs TECH Comparison

ATR vs TECH Comparison

Compare ATR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AptarGroup Inc.

ATR

AptarGroup Inc.

HOLD

Current Price

$124.27

Market Cap

7.7B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.86

Market Cap

9.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATR
TECH
Founded
1992
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
9.1B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
ATR
TECH
Price
$124.27
$58.86
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$170.25
$71.82
AVG Volume (30 Days)
439.7K
2.6M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
1.56%
0.62%
EPS Growth
6.51
N/A
EPS
1.12
0.81
Revenue
$3,777,181,000.00
$1,219,635,000.00
Revenue This Year
$5.18
$2.49
Revenue Next Year
$4.98
$6.40
P/E Ratio
$107.69
$69.46
Revenue Growth
5.42
5.23
52 Week Low
$103.23
$43.20
52 Week High
$164.28
$72.16

Technical Indicators

Market Signals
Indicator
ATR
TECH
Relative Strength Index (RSI) 66.85 64.85
Support Level $117.57 $57.46
Resistance Level $125.87 $62.88
Average True Range (ATR) 3.27 2.20
MACD 1.18 0.58
Stochastic Oscillator 93.95 88.22

Price Performance

Historical Comparison
ATR
TECH

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: